The UK has left the European Union and the transition period comes to an end on 31st Dec 2020. From 1st January 2021 there will be regulatory changes in the UK.

These changes will require some establishments to update their licenses and processes for import and export of both medicinal products (IMPs and marketed products) and tissues and cells for human application.

Please follow the links below to find the appropriate guidance for your organisation: